Gene Transfer of Secreted-Type Modified Interleukin-18 Gene to B16F10 Melanoma Cells Suppresses In Vivo Tumor Growth through Inhibition of Tumor Vessel Formation
- 1 September 2002
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 119 (3) , 541-548
- https://doi.org/10.1046/j.1523-1747.2002.01866.x
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Protective immunity is induced in murine colon carcinoma cells by the expression of interleukin-12 or interleukin-18, which activate type 1 helper T cellsCancer Gene Therapy, 2000
- Distinct functions of interferon‐γ for chemokine expression in models of acute lung inflammationImmunology, 1998
- Tumor Cell Responses to IFNγ Affect Tumorigenicity and Response to IL-12 Therapy and AntiangiogenesisImmunity, 1998
- Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis.Journal of Clinical Investigation, 1998
- The Functional Role of the ELR Motif in CXC Chemokine-mediated AngiogenesisJournal of Biological Chemistry, 1995
- Cloning of a new cytokine that induces IFN-γ production by T cellsNature, 1995
- Systemic administration of rIL-12 induces complete tumor regression and protective immunity: response is correlated with a striking reversal of suppressed IFN-γ production by anti-tumor T cellsInternational Immunology, 1995
- CD4 T cells inhibitin vivo the CD8-mediated immune response against murine colon carcinoma cells transduced with interleukin-12 genesEuropean Journal of Immunology, 1995
- Antitumor and antimetastatic activity of interleukin 12 against murine tumors.The Journal of Experimental Medicine, 1993
- Biochemical characterization of a gamma interferon-inducible cytokine (IP-10).The Journal of Experimental Medicine, 1987